No Detail Found!

Do the expression of long noncoding RNA MALAT1 and inflammatory factors help diagnose gestational diabetes in the second trimester of pregnancy?

Author(s)
Mojdeh Ghiyas Tabari Department of Clinical Biochemistry, School of Medicine, Babol University of Medical Sciences, Babol, Iran; Student Research Committee, Babol University of Medical Sciences, Babol, Iran
Farzin Sadeghi Department of Virology, School of Medicine, Babol University of Medical Sciences, Babol, Iran; Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
Mahmood Hajiahmadi Department of Biostatistics, Faculty of Medicine, Babol University of Medical Sciences,Babol,Iran
Shahnaz Barat Department of Obstetrics and Gynecology, Infertility and Reproductive Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
Hadi Parsian Department of Clinical Biochemistry, School of Medicine, Babol University of Medical Sciences, Babol, Iran; Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
Abstract
Gestational diabetes mellitus (GDM) is a common clinical disease characterized by intolerance to glucose and varying its severity in the second or third trimester of pregnancy. Inflammatory mediators such as IL-6 and TNFa are thought to contribute to the development of gestational diabetes. In addition, various long noncoding RNAs (LncRNAs) such as MALAT1 are suggested as epigenetic modifiers using chromatin-modifying complexes at specific genomic sites or promoter regions. Today, researchers are paying close attention to understand the role of LncRNAs expression status in various diseases. The study was designed to analyze the association of inflammatory mediators IL6, TNFa, and LncRNA MALAT1 expression status with the development of GDM in the second trimester of pregnancy. In this casecontrol study, 30 pregnant women diagnosed with GDM and 30 pregnant women having normal glucose tolerance tests participated. All participants were screened according to the criteria of the ADA. Expression levels of IL-6, TNFa, and MALAT1 were analyzed by q RT-PCR. The results were analyzed statistically by SPSS 22 software. There was a significant difference in the levels of IL6 (p value=0.049), but not MALAT1 and TNFa (p= 0.42 and p=0.79, respectively) in the two groups. The results of ROC analysis for discriminating of patients with GDM and healthy individuals were only reasonable for IL6 (AUC=0.771, sensitivity = 0.867, specificity = 0.733, PPV%=87, NPV%=73).Although the basic diagnosis of gestational diabetes relies on a glucose test, finding new diagnostic factors is also necessary. According to the results, it seems that IL6 expression status, along with blood glucose, can be used as diagnostic biomarkers in the diagnosis of GDM in the second trimester of pregnancy. More studies are needed for the determination of the exact role of IL6 in the pathogenesis of GDM.
Publication Details
Page(s) 798-804
DOI DOI not available
Published Journal: Bioscience Research, Volume: 19, Issue: 2, Year: 2022

Request the full text from PASTIC

Keywords
Gestational diabetes mellitus, Long non-coding RNA, interleukin-6, TNFa
0

Citations

0

Downloads

121

Views